Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy - Primary results of the SYNERGY randomized trial

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Ferguson, J. J.
  • Califf, R. M.
  • Antman, E. M.
  • Cohen, M.
  • Grines, C. L.
  • Goodman, S.
  • Kereiakes, D. J.
  • Langer, A.
  • Mahaffey, K. W.
  • Nessel, C. C.
  • Armstrong, P. W.
  • Avezum, A.
  • Aylward, P.
  • Becker, R. C.
  • Biasucci, L.
  • Borzak, S.
  • Col, J.
  • Frey, M. J.
  • Fry, E.
  • Gulba, D. C.
  • Guneri, S.
  • Gurfinkel, E.
  • Harrington, R.
  • Hochman, J. S.
  • Kleiman, N. S.
  • Leon, M. B.
  • Lopez-Sendon, J. L.
  • Pepine, C. J.
  • Ruzyllo, W.
  • Steinhubl, Steven
  • Teirstein, P. S.
  • Toro-Figueroa, L.
  • White, H.

publication date

  • 2004

journal

  • JAMA-Journal of the American Medical Association  Journal

subject areas

  • Aged
  • Angina Pectoris
  • Angioplasty, Balloon, Coronary
  • Enoxaparin
  • Female
  • Fibrinolytic Agents
  • Hemorrhage
  • Heparin
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Stroke
  • Survival Analysis
  • Treatment Outcome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0098-7484

PubMed ID

  • 15238590
scroll to property group menus

Additional Document Info

start page

  • 45

end page

  • 54

volume

  • 292

issue

  • 1

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support